A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...
Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...
GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders, today announced the appointment of Petra Duda, M.D., Ph.D., as Chief Medical Officer. Dr. Duda brings ...
As we grow older, we are likely to stop drinking this nutritious beverage, perhaps because we associate it too much with childhood and want to move on to more “grown-up” drinks like coffee and tea.
A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT ...
T-cell engagers (TCEs) have the most promising product profile across all deep B-cell depleting modalitiesCizutamig (BCMA TCE) positioned as first and best-in-class for autoimmune diseasesOver 60 ...
Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with ...
Explore the evolution of IgA nephropathy treatment, highlighting new guidelines and targeted therapies that improve patient ...
Detailed price information for Transcode Therapeutics Inc (RNAZ-Q) from The Globe and Mail including charting and trades.
Sources say Lilly is discussing a $14-a-share cash deal for Ventyx, potentially announced as soon as Wednesday.
Verywell Health on MSN
What Happens to Your Body When You Eat More Cabbage Every Week
Cabbage is a low-calorie, nutrient-rich food with multiple potential health benefits. Learn more about this cruciferous vegetable, including tips for incorporating it into your diet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback